Closing the evidence gap on cannabis, youth, and chronic pain

Last modified by Logan Green on 2020/10/05 21:40

Chronic daily headache is one of the most common pain syndromes in adolescence, reported by up to 8% of the population. Despite many available therapies and a three-pronged approach to treatment, only roughly 50% will experience remission. For those who have failed conventional treatments cannabis-based medicines may present an effective option. This session will discuss cannabis used for medical purposes in children with a focus on pain and chronic daily headache. We will share the findings from our work engaging youth in the design of clinical trials to begin to close the evidence gap on cannabis, youth and chronic pain.

Main messages:
1.     Cannabis is being used for pain management by youth and adults

2.     Cannabis-based therapies present a potential for youth with chronic daily headaches that do not respond to traditional treatments, but more research is needed to establish safety, dosing and benefit

3.      You can only improve the impact of your studies by engaging in discussions with the population during the design process

Click here to register for the webinar on October 28, 2020 from 11:00 AM to 12:00 PM EDT.

Dr. Lauren E Kelly is an Assistant Professor in the Department of Pediatrics & Child Health and in Community Health Sciences at the University of Manitoba. She is a Scientist at the Children’s Hospital Research Institute of Manitoba and a Clinical Trialist at the George and Fay Yee Centre for Healthcare Innovation. She is the Scientific Director of Canadian Childhood Cannabinoid Clinical Trials (www.C4Trials.org), a research platform that studies the safety of cannabis products used for medical purposes in the pediatric population. Dr. Kelly received a PhD in Pharmacology and Toxicology from the University of Western Ontario where her graduate work focused on identifying genetic and clinical risk factors for opioid toxicity in children. She completed two Post-doctoral Fellowships at the Hospital for Sick Children and at Mount Sinai Hospital in Toronto. Dr. Kelly’s SickKids New Investigator Award will look at engaging youth in the design of clinical studies on cannabis products. Her team will complete a youth and parent-informed tolerability study with adolescents diagnosed with chronic daily headache who have failed multiple existing therapies from across Canada. 

Tags:
Created by Logan Green on 2020/10/05 20:56